Analystreport

PTC Therapeutics (NASDAQ:PTCT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $73.00 price target on the stock.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com